ASSFN Society News
M. Sindou(Université Claude Bernard Lyon 1), Yair Safriel, Ruben Geevarghese, Steven Falowski, Nikunj Patel, Douglas Kondziolka(Neurological Surgery), George Georgoulis, Byung-chul Son, Sihoon Lee, Manmeet S. Alhuwalia, Amy Tyburczy(NYU Langone Health), Keyoumars Ashkan(Haywards Heath Hospital), Caitlyn Doody(NYU Langone Health), Takaomi Taira, Brian Yeh(NYU Langone Health), Ruth Tuura(University of Zurich), Sang-woo Ha, Jeffrey Voigt, Anthony E. Pickering, Takakazu Kawamata(Tokyo Women's Medical University Hospital), Mark L. Kuijf, Hugh Sims-Williams(Tenwek Hospital), Melissa A. LoPresti(NYU Langone Health), Shiro Horisawa, Ning-Ning Dou, Linda Ackermans(Maastricht University Medical Centre), Yasin Temel(University Medical Center), Gene H. Barnett(Cleveland Clinic), Pieter Kubben(Maastricht University), Cassandra Golden(NYU Langone Health), Lynda Boulio(NYU Langone Health), Joshua S. Silverman(NYU Langone Health), Shinichi Goto, Albert F.G. Leentjes, Bin Li(State Key Laboratory of Respiratory Disease), Jiyeon Kim, Sung‐Hoon Kim(Yonsei University), Lei Xia(Tongji University), Mingxing Liu, Jin-gyu Choi(Yeouido St. Mary's Hospital), Jun Zhong(Shanghai Jiao Tong University), Shiting Li(Shanghai Jiao Tong University), Shazia Javed, Michael C. Samuel, Young Min Shon, Nobuhiko Takeda, Yuki Takano, Timmy Seto(NYU Langone Health), Hui Sun, Daniel E. Lumsden
Cited by 0
Related Papers
Targeting PI3K/Akt signal transduction for cancer therapy
|Signal Transduction and Targeted Therapy|2021|1.7k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Advances in targeted therapy for esophageal cancer
|Signal Transduction and Targeted Therapy|2020|546